| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 63 |
| 1 | TERIPARATIDE | 15 |
| 2 | ALENDRONATE SODIUM | 14 |
| 3 | LEVOTHYROXINE SODIUM | 13 |
| 4 | ROMOSOZUMAB-AQQG | 10 |
| 5 | CALCIUM | 8 |
| 6 | ASPIRIN | 6 |
| 7 | ASPIRIN 325 MG | 6 |
| 8 | ASPIRIN 81 MG | 6 |
| 9 | OMEPRAZOLE MAGNESIUM | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIACINAMIDE, ZINC GLYCINATE, LEVOMEFOLATE CALCIUM, CUPRIC OXIDE, SELENIUM AND CHROMIUM | 1 | 0.0278 |
| 1 | NITROGEN | 1 | 0.0095 |
| 2 | TRASTUZUMAB-DKST | 1 | 0.0038 |
| 3 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | 1 | 0.0038 |
| 4 | ERGOTAMINE TARTRATE AND CAFFEINE | 1 | 0.0037 |
| 5 | FLUTAMIDE | 1 | 0.0010 |
| 6 | ROMOSOZUMAB-AQQG | 10 | 0.0007 |
| 7 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 8 | LEVOMILNACIPRAN HYDROCHLORIDE | 1 | 0.0005 |
| 9 | TRANDOLAPRIL TABLETS | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | RANK Ligand Inhibitor [EPC] | 63 |
| 1 | Parathyroid Hormone Analog [EPC] | 15 |
| 2 | Corticosteroid [EPC] | 11 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 4 | Calcium [EPC] | 8 |
| 5 | Aromatase Inhibitor [EPC] | 7 |
| 6 | Benzodiazepine [EPC] | 7 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 7 |
| 8 | Proton Pump Inhibitor [EPC] | 7 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progestin Antagonist [EPC] | 2 | 0.0004 |
| 1 | Calcitonin [EPC] | 1 | 0.0003 |
| 2 | RANK Ligand Inhibitor [EPC] | 63 | 0.0003 |
| 3 | Vitamin K [EPC] | 2 | 0.0002 |
| 4 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Parathyroid Hormone-Related Peptide Analog [EPC] | 5 | 0.0002 |
| 6 | Parathyroid Hormone Analog [EPC] | 15 | 0.0001 |
| 7 | Cannabinoid [EPC] | 1 | 0.0001 |
| 8 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 3 | 0.0001 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |